8-K//Current report
Amylyx Pharmaceuticals, Inc. 8-K
Accession 0000950170-25-066355
$AMLXCIK 0001658551operating
Filed
May 7, 8:00 PM ET
Accepted
May 8, 7:01 AM ET
Size
332.4 KB
Accession
0000950170-25-066355
Documents
- 8-Kamlx-20250508.htmPrimary
8-K
- EX-99.1amlx-ex99_1.htm
EX-99.1
- GRAPHICimg212534189_0.jpg
GRAPHIC
- EX-101.SCHamlx-20250508.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-066355-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLamlx-20250508_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001658551
Filing Metadata
- Form type
- 8-K
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 7:01 AM ET
- Size
- 332.4 KB